Suppr超能文献

乳腺癌患者中细胞因子IL-5、IL-6、IL-8、IL-17和VEGF的表达分析

Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients.

作者信息

Liu Gang, Chen Xiang-Ting, Zhang Hao, Chen Xin

机构信息

Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Department of Neurology, Bishan Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Oncol. 2022 Dec 1;12:1019247. doi: 10.3389/fonc.2022.1019247. eCollection 2022.

Abstract

OBJECTIVE

To investigate the relationship between changes in peripheral blood vascular endothelial growth factor (VEGF), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-17 (IL-17) concentrations in breast cancer patients and their significance and clinical value in breast cancer staging and invasive metastasis.

METHODS

From September 2021 to April 2022, 60 breast cancer patients from Chongqing Medical University Hospital No. 2022 were enrolled in the breast breast cancer surgery group, while 30 patients with benign breast disease were enrolled in the control group during the same period. Venous blood samples were collected at admission and 1 week after surgery to determine the expression of these factors in serum. Statistical methods such as Wilcoxon test and Spearman correlation analysis were used to analyze the relationship between the above factors and the clinicopathological characteristics of the patients.

RESULTS

By analyzing data from patients with benign and malignant breast tumors, an association was found with serum levels of IL-6, IL-17 and VEGF. Their respective areas under the operating characteristic curve were 0.649, 0.734 and 0.656 (P < 0.05). There were significant differences in the cytokine expression levels of IL-17 and VEGF in different molecular typing (P values were 0.008 and 0.040, respectively). The expression levels of IL-17 and VEGF were higher in HER-2 receptor-positive and triple-negative patients than in hormone receptor-positive patients (P < 0.05). Also, no significant correlation was found between the various cytokines mentioned in the article and breast cancer lymph node metastasis and Tumor Node Metastasis stage (TNM stage). In addition, in the breast cancer surgery group, postoperative VEGF levels were lower (P < 0.05) and IL-6 levels were higher (P < 0.05) compared to preoperative levels.

CONCLUSIONS

Serum IL-6, IL-17, and VEGF are strongly associated with breast cancer development and can be used as a reference indicators for breast cancer diagnosis. In addition, post-operative VEGF levels decreases and IL-6 levels increases compared to pre-operative levels, which can also be used as an a postoperative follow-up indicator. In contrast, IL-5 and IL-8 have not found to be significantly associated with breast cancer patients in this study, which requires further study.

摘要

目的

探讨乳腺癌患者外周血血管内皮生长因子(VEGF)、白细胞介素-5(IL-5)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)和白细胞介素-17(IL-17)浓度变化及其在乳腺癌分期和侵袭转移中的意义与临床价值。

方法

选取2021年9月至2022年4月重庆医科大学附属第二医院的60例乳腺癌患者纳入乳腺癌手术组,同期选取30例乳腺良性疾病患者作为对照组。入院时及术后1周采集静脉血样本,检测血清中这些因子的表达。采用Wilcoxon检验和Spearman相关性分析等统计方法分析上述因子与患者临床病理特征的关系。

结果

通过分析乳腺良恶性肿瘤患者的数据,发现血清IL-6、IL-17和VEGF水平存在关联。它们各自的操作特征曲线下面积分别为0.649、0.734和0.656(P<0.05)。不同分子分型中IL-17和VEGF的细胞因子表达水平存在显著差异(P值分别为0.008和0.040)。HER-2受体阳性和三阴性患者中IL-17和VEGF的表达水平高于激素受体阳性患者(P<0.05)。此外,本文提及的各种细胞因子与乳腺癌淋巴结转移及肿瘤-淋巴结-转移分期(TNM分期)之间未发现显著相关性。另外,在乳腺癌手术组中,术后VEGF水平降低(P<0.05),IL-6水平升高(P<0.05)。

结论

血清IL-6、IL-17和VEGF与乳腺癌发生密切相关,可作为乳腺癌诊断的参考指标。此外,与术前相比,术后VEGF水平降低,IL-6水平升高,也可作为术后随访指标。相比之下,本研究未发现IL-5和IL-8与乳腺癌患者有显著关联,这需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ccc/9753904/22fa8e6bda5a/fonc-12-1019247-g001.jpg

相似文献

1
Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients.
Front Oncol. 2022 Dec 1;12:1019247. doi: 10.3389/fonc.2022.1019247. eCollection 2022.
4
Diagnostic value of serum vascular endothelial growth factor and interleukin-17 in primary hepatocellular carcinoma.
World J Gastrointest Surg. 2024 Sep 27;16(9):2934-2941. doi: 10.4240/wjgs.v16.i9.2934.
6
Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Mol Cell Biochem. 2019 Jul;457(1-2):93-103. doi: 10.1007/s11010-019-03515-w. Epub 2019 Apr 16.
8
Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer.
Medicine (Baltimore). 2017 Nov;96(45):e8488. doi: 10.1097/MD.0000000000008488.
9
Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
J Natl Cancer Inst. 1997 Jan 15;89(2):139-47. doi: 10.1093/jnci/89.2.139.
10
[Association of JMJD3, MMP-2 and VEGF expressions with clinicopathological features of invasive ductal breast carcinoma].
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Nov 30;40(11):1593-1600. doi: 10.12122/j.issn.1673-4254.2020.11.09.

引用本文的文献

1
Expression Profile of , , , and in Breast Tumors.
Int J Mol Sci. 2025 Aug 14;26(16):7841. doi: 10.3390/ijms26167841.
2
The Regulatory Role of CTCF in IL6 Gene Transcription Assessed in Breast Cancer Cell Lines.
Pharmaceuticals (Basel). 2025 Feb 23;18(3):305. doi: 10.3390/ph18030305.
4
ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.
Cell Death Dis. 2024 Apr 12;15(4):260. doi: 10.1038/s41419-024-06643-4.
5
Engineered Tumor-Immune Microenvironment On A Chip to Study T Cell-Macrophage Interaction in Breast Cancer Progression.
Adv Healthc Mater. 2024 Jun;13(14):e2303658. doi: 10.1002/adhm.202303658. Epub 2024 Feb 25.
6
Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO.
Front Oncol. 2023 Dec 7;13:1307956. doi: 10.3389/fonc.2023.1307956. eCollection 2023.
7
Interleukin 17 in early invasive breast cancer.
Front Oncol. 2023 Jun 23;13:1171254. doi: 10.3389/fonc.2023.1171254. eCollection 2023.

本文引用的文献

1
Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Acta Biomater. 2021 Nov;135:567-581. doi: 10.1016/j.actbio.2021.09.003. Epub 2021 Sep 8.
2
Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer.
Breast Cancer Res Treat. 2020 Apr;180(2):311-319. doi: 10.1007/s10549-020-05540-6. Epub 2020 Jan 29.
3
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
Clin Breast Cancer. 2019 Aug;19(4):e522-e533. doi: 10.1016/j.clbc.2019.03.006. Epub 2019 Apr 4.
5
The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway.
Oncotarget. 2017 Dec 6;8(69):113360-113372. doi: 10.18632/oncotarget.23008. eCollection 2017 Dec 26.
6
Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer.
Immunol Invest. 2017 Oct;46(7):677-688. doi: 10.1080/08820139.2017.1360342.
7
Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF.
Nat Cell Biol. 2017 Aug;19(8):974-987. doi: 10.1038/ncb3578. Epub 2017 Jul 24.
8
Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis.
Med Sci Monit. 2016 Jun 20;22:2113-8. doi: 10.12659/msm.896355.
10
Role of interleukin-6 in cancer progression and therapeutic resistance.
Tumour Biol. 2016 Sep;37(9):11553-11572. doi: 10.1007/s13277-016-5098-7. Epub 2016 Jun 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验